Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs ...

But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn ...

Engagement will assess KALA’s clinical assets, development options, and AI-enabled analytical opportunities, including the ...

Can tiny biological production factories ever give petrochemicals or animals a run for their money? 21st Bio weighs ...

Study results finalized on schedule support FDA clearance and planned U.S. commercial launchCompany advances second phase of clinical program for ...

Zura Bio (ZURA) stock update: tibulizumab enters Phase 2 for HS/SSc, cash runway to 2028, and key differentiation risks.

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations.

Q4 2025 Earnings Call March 31, 2026 10:00 AM EDTCompany ParticipantsMichael DePasquale - Chairman & CEOCecilia ...

Seafood, insect, and mushroom industries generate chitin waste. New processing converts it into high-purity chitosan for ...

Business - Boris Azarenko is a Russian entrepreneur and co-founder of Vesper, a Moscow-based developer of high-end ...

Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer treatment, announced the company has amended its existing exclusive license agreement for ...

Among these, the WPC (Wood Plastic Composite) wall panel stands out as a transformative solution, offering the warmth of ...